| Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study VK Jaeger, EG Wirz, Y Allanore, P Rossbach, G Riemekasten, E Hachulla, ... PloS one 11 (10), e0163894, 2016 | 220 | 2016 |
| The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a … G Valentini, M Iudici, UA Walker, VK Jaeger, M Baron, P Carreira, ... Annals of the Rheumatic Diseases 76 (1), 270-276, 2017 | 183 | 2017 |
| Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow … E Croce, C Hatz, EF Jonker, LG Visser, VK Jaeger, S Bühler Vaccine 35 (9), 1216-1226, 2017 | 175 | 2017 |
| High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia-a prospective observational multicentre cohort … E Kuenzli, VK Jaeger, R Frei, A Neumayr, S DeCrom, S Haller, J Blum, ... BMC infectious diseases 14, 528-528, 2014 | 153 | 2014 |
| Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma … W Wu, S Jordan, N Graf, J de Oliveira Pena, J Curram, Y Allanore, ... Annals of the rheumatic diseases 78 (5), 648-656, 2019 | 106 | 2019 |
| Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database EG Wirz, VK Jaeger, Y Allanore, G Riemekasten, E Hachulla, O Distler, ... Annals of the rheumatic diseases, annrheumdis-2015-207271, 2015 | 98 | 2015 |
| Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group VK Jaeger, O Distler, B Maurer, L Czirják, V Lóránd, G Valentini, S Vettori, ... Rheumatology, kex182, 2017 | 83 | 2017 |
| Immune reconstitution after allogeneic hematopoietic stem cell transplantation and association with occurrence and outcome of invasive aspergillosis C Stuehler, E Kuenzli, VK Jaeger, V Baettig, F Ferracin, Z Rajacic, ... The Journal of infectious diseases 212 (6), 959-967, 2015 | 70 | 2015 |
| Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study VK Jaeger, HM Hoffman, T van der Poll, H Tilson, J Seibert, A Speziale, ... Rheumatology 56 (9), 1484-1491, 2017 | 64 | 2017 |
| Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis M Becker, N Graf, R Sauter, Y Allanore, J Curram, CP Denton, D Khanna, ... Annals of the Rheumatic Diseases, annrheumdis-2019-215145, 2019 | 56 | 2019 |
| A profile of travelers—an analysis from a large Swiss travel clinic S Bühler, R Rüegg, R Steffen, C Hatz, VK Jaeger Journal of travel medicine 21 (5), 324-331, 2014 | 49 | 2014 |
| Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study A Bischof, VK Jaeger, RDM Hadden, RA Luqmani, AK Pröbstel, ... Neurology-Neuroimmunology Neuroinflammation 6 (6), e615, 2019 | 42 | 2019 |
| The elderly, the young and the pregnant traveler--A retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever … VK Jaeger, N Tschudi, R Rüegg, C Hatz, S Bühler Travel medicine and infectious disease 13 (6), 475-484, 2015 | 42 | 2015 |
| Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study VK Jaeger, M Tikly, D Xu, E Siegert, E Hachulla, P Airò, G Valentini, ... Rheumatology 59 (7), 1684-1694, 2020 | 39 | 2020 |
| Mitochondrial DNA mutations and respiratory chain dysfunction in idiopathic and connective tissue disease-related lung fibrosis VK Jaeger, D Lebrecht, AG Nicholson, A Wells, H Bhayani, A Gazdhar, ... Scientific reports 9 (1), 1-8, 2019 | 39 | 2019 |
| Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response O Mayorga, S Bühler, VK Jaeger, S Bally, C Hatz, G Frösner, U Protzer, ... The Journal of infectious diseases 214 (10), 1498-1506, 2016 | 38 | 2016 |
| Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the … G Valentini, D Huscher, A Riccardi, S Fasano, R Irace, V Messiniti, ... Annals of the Rheumatic Diseases 78 (11), 1576-1582, 2019 | 37 | 2019 |
| Rituximab done: what’s next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in … UA Walker, VK Jaeger, K Chatzidionysiou, ML Hetland, EM Hauge, ... Rheumatology 55 (2), 230-236, 2016 | 34 | 2016 |
| Disease activity dynamics in rheumatoid arthritis: patients’ self-assessment of disease activity via WebApp UA Walker, RB Mueller, VK Jaeger, R Theiler, A Forster, P Dufner, F Ganz, ... Rheumatology, 2017 | 33 | 2017 |
| Individual social contact data and population mobility data as early markers of SARS-CoV-2 transmission dynamics during the first wave in Germany—an analysis based on the … DV Tomori, N Rübsamen, T Berger, S Scholz, J Walde, I Wittenberg, ... BMC medicine 19 (1), 1-13, 2021 | 30 | 2021 |
